artesunate brands
84 registered brands containing artesunate in Kenya.
artesunate
PubChem CID 6917864Molecular formula: C19H28O8
Artesunate is metabolized to the active DHA. the endoperoxide bridge of DHA reacts with heme, generating free radicals which inhibit protein and nucleic acid synthesis of the _Plasmodium_ parasites during all erythrocytic stages. Reactions with these free radicals can also lead to alkylation of parasitic proteins such as a calcium adenosine triphosphatase and EXP1, a glutathione S-transferase. Two theories have been put forward for the mode of antimalarial action of the artemisinin antimalarials, in accodance with the known properties of peroxides with medicinal activity. The first assumes that the artemisinins must be activated by contact with either reduced haem (ferrous haem, Fe(ll)PPIX) or non-haem ferrous iron (exogenous iron), causing cleavage of the peroxide to generate oxygen-centered radicals (alkoxy radicals') which are the presumed to be converted into carbon-centered radicals by transfer of proximate hydrogen atoms from the periphery of the peroxide molecule. These carbon-centered radicals are then thought to alkylate sensitive, yet unspecified, biomolecules in the parasite. A second theory argues for a process in which the intact artemisinin binds to a site within a vital protein in the parasite. The act of binding causes the peroxide to be converted to hydroperoxide or similar open peroxide, which in accordance with known properties of such compounds, generates one or more active chemical entities, either oxidizing agents or oxygen transfer agents per se, or oxygen-centered free radicals. This would be associated with the binding process. In such a way, the artemisinins might act as (irreversibile) inhibitors. Iron may, or may not, be associated with the activation process. No specific biological target in the parasite has yet been identified in support of this theory, but it may be membrane-bound proteins. Artesunate is a water soluble derivative of artemisinin, an antimalarial compound isolated from the Chinese herb Qinghao (Artemisia annua). Artesunate is rapidly metabolized to dihydroartemisinin (DHA) in the body. Chemically, artesunate, and its active metabolite, DHA, are sesquiterpene lactones with a trioxane ring containing a peroxide bridge. The peroxide bridge appears to be essential for the antimalarial activity of artesunate. Structure-activity relationship studies show that the deoxy derivative of DHA (that lack the peroxide bridge) was 277-fold less active than DHA. The activity of deoxyartesunate was not measured. Deoxy derivatives of other artemisinin analogs were 10- to 1000-fold less active compared to the parent compounds. Artesunate increases superoxide anion production and lipid peroxidation in falciparum-infected erythrocytes in vitro. However, artesunate does not suppress the activity of antioxidant enzymes (superoxide dismutase, catalase, glutathione reductase, and glutathione peroxidase) in infected or uninfected erythrocytes. Erythrocytes infected with the ring or trophozoite forms in vitro accumulate 100- and 180- fold higher concentrations of DHA (12 nM ie, 3.40 ng/mL), respectively, compared to uninfected erythrocytes. These experiments were performed in a medium containing 10% human serum. The relevance of these findings to the uptake in vivo is unclear. The precise mechanism by which artesunate exhibits antiplasmodial activity is not understood. A 2025 systematic review notes Artesunate's pharmacological activities (antimalarial, antiparasite,antitumor, antivirus, antiinflammation, and antibacterial),and that it is a highly effective antimalarial agent with the potential to induce organ toxicity under certain conditions. The authors note that mechanisms of Artesunate-induced toxicity include oxidative stress, inflammation, and apoptotic signaling patthhways.They also note that Artesunate ameliorates MASH (Metabolic Dysfunction-Associated Steatohepatitis) by reducing inflammation and lipid accumulation by regulating NLRP3 inflammasome and reducing lipid accumulation (SREBP-1c, FAS).
Source: PubChem (NCBI) · compound 6917864
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| ARTRIN 140MG TAB ARTESUNATE 120MG + LUMEFANTRINE 20MG |
Sanofi Aventis | Registered | Kenya |
| AUSNART 60 MG INJ 60MG |
Aushnlife | Registered | Kenya |
| AZUNATE INJECTION 60MG 60MG |
Sai Pharmaceuticals | Registered | Kenya |
| CO-ARINATE FDC ADULT 200 MG ARTESUNATE 500 MG SULFAMETHOXYPYRAZINE 25 MG PYRIMETHAMINE |
Energia Pharma | Registered | Kenya |
| Co-Arinate FDC adult Tablet |
Dafra Pharma GMBH | Retained | Kenya |
| CO-ARINATE FDC JUNIOR 100 MG ARTESUNATE 250 MG SULFAMETHOXYPYRAZINE 125 MG PYRIMETHAMINE |
Energia Pharma | Registered | Kenya |
| Co-Arinate FDC junior Tablet |
Dafra Pharma GMBH | Retained | Kenya |
| DUNATE INJECTION 60MG |
Nairobi Enterprises | Registered | Kenya |
| FALCICARE 60MG |
Kentons | Registered | Kenya |
| FALCIMON 100/270MG B/L ARTESUNATE 100MG - AMODIAQUINE 270MG |
Phillips Healthcare | Registered | Kenya |
| FALCIMON 25/67.5MG B/L ARTESUNATE 25MG & AMODIAQUINE 67.5MG |
Phillips Healthcare | Registered | Kenya |
| FALCIMON 50/135 B/L ARTESUNATE 50MG , AMODIAQUINE 135MG |
Phillips Healthcare | Registered | Kenya |
| FALCINIL ARTESUNATE 60MG |
Lords Healthcare | Registered | Kenya |
| GSUNATE INJECTION ARTESUNATE 60MG |
Theralife Pharma | Registered | Kenya |
| GSUNATE-120 ARTESUNATE 120 MG |
Theralife Pharma | Registered | Kenya |
| GSUNATE-200 200MG |
Theralife Pharma | Registered | Kenya |
| GSUNATE-50 EACH SUPPOSITORY CONTAINS: ARTESUNATE 50MG |
Theralife Pharma | Registered | Kenya |
| INDART-120 INJECTION 120MG |
Sai Pharmaceuticals | Registered | Kenya |
| INDART-60 INJECTION 60MG |
Sai Pharmaceuticals | Registered | Kenya |
| INDART-60 PLUS ARTESUNATE 60MG |
Sai Pharmaceuticals | Registered | Kenya |
| LARINATE 120 EACH COMBIPACK CONTAINS: EACH VIAL CONTAINS: ARTESUNATE PH.INT. (STERILE) 120 MG |
Sai Pharmaceuticals | Registered | Kenya |
| LARINATE INJECTION 60 MG PER VIAL |
Sai Pharmaceuticals | Registered | Kenya |
| LYSUNATE INJECTION 60MG (COMBI-PACK) 60MG |
Harleys | Registered | Kenya |
| M-SUNATE INJECTON ARTESUNATE 60MG / VIAL |
Dawa | Registered | Kenya |
| MACSUNATE AQ FORTE TABLETS ARTESUNATE 100MG AMODIAQUINE HYDROCHLORIDE 270MG |
Sai Pharmaceuticals | Registered | Kenya |
| MACSUNATE AQ JUNIOR TABLETS 50/135 |
Sai Pharmaceuticals | Registered | Kenya |
| MACSUNATE AQ KID TABLETS 25MG/67.5MG |
Sai Pharmaceuticals | Registered | Kenya |
| MALART 60 60 MG |
Zawadi Healthcare | Registered | Kenya |
| NOVOARTESUN-60 ARTESUNATE 60MG INJECTION + 1ML AMPOULE OF SODIUM BICARBONATE INJECTION 5% W/V + 5ML AMPOULE OF SODIUM CHLORIDE INJECTION 0.9% W/V |
Novogen Supplies | Registered | Kenya |
| PLASMOTRIM-200 RECTOCAPS ARTESUNATE 200 MG |
Acino Pharma | - | Kenya |
| PLASMOTRIM-50 RECTOCAPS ARTESUNATE 50 MG |
Goodman Agencies | Registered | Kenya |
| PYRAMAX GRANULES FOR ORAL SUSPENSION EACH SACHET OF PYRAMAX GRANULES FOR ORAL SUSPENSION CONTAINS 60 MG PYRONARIDINE TETRAPHOSPHATE AND 20 MG ARTESUNATE |
Perspective Healthcare | Registered | Kenya |
| PYRAMAX TABLET EACH PYRAMAX TABLET CONTAINS 180 MG OF PYRONARIDINE TETRAPHOSPHATE AND 60 MG OF ARTESUNATE. |
Perspective Healthcare | Registered | Kenya |
| SUNAT 60 INJECTION EACH COMBIPACK CONTAINS: ARTESUNATE INJECTION 60 MG EACH VIAL CONTAINS: ARTESUNATE 60 MG,SODIUM BICARBONATE INJECTION USP (1ML) EACH AMPOULE CONTAINS: SODIUM BICARBONATE USP 5% W/V , WATER FOR INJECTION USP .Q.S., SODIUM CHLORIDE INJECTION USP (5ML) |
Shalina Healthcare | Registered | Kenya |